Global Nutraceutical Ingredients Market was valued at USD XX Billion in the year 2020. Global Nutraceutical Ingredients Market is further estimated to grow at a CAGR of XX% from 2021 to 2030 and it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2020 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development. The Global Nutraceutical Ingredients Report 2020-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section. On the basis of Type, the market is divided as Probiotics, Proteins, Amino Acids, Phytochemicals & Plant Extracts, Fibers & Specialty Carbohydrates. In which Probiotics for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW. Market player analysis of major companies such as Ajinomoto Inc., Cargill, Archer Daniels Midland Company, BASF SE, Associated British Foods, Ingreidon, Koninjklike DSM NV, Arla Foods, Tate and Lyle PLC, EI Du Pont De Nemours, and others.
Scope:
Report Data
Market
Forecast 2022
XX million/billion (2022-2032)
CAGR 2022 - 2032
%
Analysis Period
2022 - 2032
Base Year
2021
Forecast Data
2022 - 2032
Segments Covered
By Type, By Application, And by Regions
Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
1 INTRODUCTION 1.1 OBJECTIVES 1.2 MARKET DEFINITION 1.2.1 MARKET SCOPE 1.3 RESEARCH METHODOLOGY 1.3.1 SECONDARY DATA 1.3.2 PRIMARY DATA 1.3.3 MARKET SIZE ESTIMATION 1.3.4 MARKET BREAKDOWN AND DATA TRIANGULATION 1.4 STAKEHOLDERS 1.5 CURRENCY 1.6 RESEARCH ASSUMPTIONS 1.7 LIMITATION 2 EXECUTIVE SUMMARY 3 MARKET OUTLOOK 3.1 INTRODUCTION 3.2 DROC MATRIX 3.3 MARKET CHALLENGES 3.4 MARKET SHARE ANALYSIS 3.5 COST STRUCTURE ANALYSIS 3.6 VALUE CHAIN ANALYSIS 3.7 COVID-19 IMPACT ANALYSES 4 INDUSTRY TRENDS 4.1 INTRODUCTION 4.2 PESTEL ANALYSIS 4.3 PORTER’S FIVE FORCES MODEL 4.3.1 DEGREE OF COMPETITION 4.3.2 BARGAINING POWER OF BUYERS 4.3.3 BARGAINING POWER OF SUPPLIERS 4.3.4 THREAT FROM SUBSTITUTES 4.3.5 THREAT FROM NEW ENTRANTS 5 NUTRACEUTICAL INGREDIENTS TYPE ANALYSIS 5.1 INTRODUCTION 5.2 HISTORICAL MARKET TYPE ANALYSIS, 2015-2019 5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030 5.4 Y-O-Y GROWTH TREND ANALYSIS 5.5 PREBIOTICS 5.6 PROBIOTICS 5.7 PROTEINS & AMINO ACIDS 5.8 VITAMINS 5.9 MINERALS 5.10 OMEGA-3 FATTY ACIDS 5.11 CAROTENOIDS 5.12 FIBERS & SPECIALTY CARBOHYDRATES 5.13 PHYTOCHEMICAL AND PLANT EXTRACTS 5.14 OTHERS (GLUCOSAMINE, CHONDROITIN, POYOLSPOLYOLS, AND OTHER SATURATED FATTY ACIDS) 6 NUTRACEUTICAL INGREDIENTS MARKET FORM ANALYSIS 6.1 INTRODUCTION 6.2 HISTORICAL MARKET FORM ANALYSIS, 2015-2019 6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030 6.4 Y-O-Y GROWTH TREND ANALYSIS 6.5 DRY 6.6 LIQUID 7 NUTRACEUTICAL INGREDIENTS MARKET HEALTH BENEFITS ANALYSIS 7.1 INTRODUCTION 7.2 HISTORICAL MARKET HEALTH BENEFITS ANALYSIS, 2015-2019 7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030 7.4 Y-O-Y GROWTH TREND ANALYSIS 7.5 COGNITIVE HEALTH 7.6 GUT HEALTH 7.7 HEART HEALTH 7.8 BONE HEALTH 7.9 IMMUNITY 7.10 NUTRITION 7.11 WEIGH MANAGEMENT 7.12 OTHERS 8 NUTRACEUTICAL INGREDIENTS MARKET APPLICATION ANALYSIS 8.1 INTRODUCTION 8.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019 8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030 8.4 Y-O-Y GROWTH TREND ANALYSIS 8.5 FOOD 8.6 BEVERAGES 8.7 PERSONAL CARE 8.8 ANIMAL NUTRITION 8.9 DIETARY SUPPLEMENTS 9 GLOBAL NUTRACEUTICAL INGREDIENTS REGIONAL ANALYSIS 9.1 INTRODUCTION 9.2 NORTH AMERICA 9.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019 9.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030 9.2.3 Y-O-Y GROWTH TREND ANALYSIS 9.2.3.1 U.S. 9.2.3.2 Canada 9.2.3.3 Mexico 9.3 ASIA-PACIFIC 9.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019 9.3.2 Y-O-Y GROWTH TREND ANALYSIS 9.3.2.1 China 9.3.2.2 Japan 9.3.2.3 Korea 9.3.2.4 India 9.3.2.5 Southeast Asia 9.4 MIDDLE EAST AND AFRICA 9.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019 9.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030 9.4.3 Y-O-Y GROWTH TREND ANALYSIS 9.4.3.1 Saudi Arabia 9.4.3.2 UAE 9.4.3.3 Egypt 9.4.3.4 Nigeria 9.4.3.5 South Africa 9.5 EUROPE 9.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019 9.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030 9.5.3 Y-O-Y GROWTH TREND ANALYSIS 9.5.3.1 Germany 9.5.3.2 France 9.5.3.3 UK 9.5.3.4 Russia 9.5.3.5 Italy 9.6 SOUTH AMERICA 9.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019 9.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030 9.6.3 Y-O-Y GROWTH TREND ANALYSIS 9.6.3.1 Brazil 9.6.3.2 Argentina 9.6.3.3 Columbia 10 MARKET PLAYERS 10.1 CARGILL 10.1.1 BUSINESS OVERVIEW: 10.1.2 PRODUCT PORTFOLIO 10.1.3 RECENT DEVELOPMENTS 10.1.4 SWOT ANALYSIS: 10.2 I. DU PONT DE NEMOURS AND COMPANY 10.3 BASF SE 10.4 ARCHER DANIELS MIDLAND COMPANY 10.5 ASSOCIATED BRITISH FOODS PLC (U.K). 10.6 KONINKLIJKE DSM N.V. 10.7 INGREDION INCORPORATED 10.8 AJINOMOTO CO., INC. 10.9 ARLA FOODS 10.10 TATE & LYLE PLC 10.11 INGREIDON 10.12 EI DU PONT DE NEMOURS 10.13 DSM 11 ABOUT US
TABLE 1 NUTRACEUTICAL INGREDIENTS REGIONAL ANALYSIS, 2020–2030 (USD MILLION) TABLE 2 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, 2020–2030, (USD MILLION) TABLE 3 NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE REGIONAL ANALYSIS, 2020–2030 (USD MILLION) TABLE 4 GLOBAL NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET TYPE ANALYSIS, 2015-2019, (USD MILLION) TABLE 5 NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION) TABLE 6 GLOBAL NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET FORM ANALYSIS, 2015-2019, (USD MILLION) TABLE 7 NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE FORM ANALYSIS, 2020–2030 (USD MILLION) TABLE 8 GLOBAL NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET HEALTH BENEFITS ANALYSIS, 2015-2019, (USD MILLION) TABLE 9 NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE HEALTH BENEFITS ANALYSIS, 2020–2030 (USD MILLION) TABLE 10 GLOBAL NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019, (USD MILLION) TABLE 11 NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION) TABLE 12 NORTH AMERICA NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION) TABLE 13 NORTH AMERICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION) TABLE 14 NORTH AMERICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE FORM ANALYSIS, 2020–2030 (USD MILLION) TABLE 15 NORTH AMERICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE HEALTH BENEFITS ANALYSIS, 2020–2030 (USD MILLION) TABLE 16 NORTH AMERICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION) TABLE 17 U.S. NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2015–2020 TABLE 18 U.S. NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 19 U.S. NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 20 CANADA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 21 CANADA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 22 MEXICO NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 23 MEXICO NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 24 APAC NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION) TABLE 25 ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION) TABLE 26 ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE FORM ANALYSIS, 2020–2030 (USD MILLION) TABLE 27 ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE HEALTH BENEFITS ANALYSIS, 2020–2030 (USD MILLION) TABLE 28 ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION) TABLE 29 CHINA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 30 CHINA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 31 JAPAN NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 32 JAPAN NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 33 KOREA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 34 KOREA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 35 INDIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 36 INDIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 37 SOUTHEAST ASIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 38 SOUTHEAST ASIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 39 MIDDLE EAST AND AFRICA NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION) TABLE 40 MIDDLE EAST AND AFRICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION) TABLE 41 MIDDLE EAST AND AFRICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE FORM ANALYSIS, 2020–2030 (USD MILLION) TABLE 42 MIDDLE EAST AND AFRICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE HEALTH BENEFITS ANALYSIS, 2020–2030 (USD MILLION) TABLE 43 MIDDLE EAST AND AFRICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION) TABLE 44 SAUDI ARABIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 45 SAUDI ARABIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 46 UAE NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 47 UAE NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 48 EGYPT NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 49 EGYPT NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 50 NIGERIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 51 NIGERIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 52 SOUTH AFRICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 53 SOUTH AFRICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 54 EUROPE NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION) TABLE 55 EUROPE NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION) TABLE 56 EUROPE NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE FORM ANALYSIS, 2020–2030 (USD MILLION) TABLE 57 EUROPE NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE HEALTH BENEFITS ANALYSIS, 2020–2030 (USD MILLION) TABLE 58 EUROPE NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION) TABLE 59 GERMANY NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 60 GERMANY NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 61 FRANCE NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 62 FRANCE NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 63 UK NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 64 UK NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 65 RUSSIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 66 RUSSIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 67 ITALY NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 68 ITALY NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 69 SOUTH AMERICA NUTRACEUTICAL INGREDIENTS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION) TABLE 70 SOUTH AMERICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION) TABLE 71 SOUTH AMERICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE FORM ANALYSIS, 2020–2030 (USD MILLION) TABLE 72 SOUTH AMERICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE HEALTH BENEFITS ANALYSIS, 2020–2030 (USD MILLION) TABLE 73 SOUTH AMERICA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION) TABLE 74 BRAZIL NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 75 BRAZIL NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 76 ARGENTINA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 77 ARGENTINA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION) TABLE 78 COLUMBIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION) TABLE 79 COLUMBIA NUTRACEUTICAL INGREDIENTS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
Frequently Asked Questions
What is the future market value of the ?
The current market value for is expected USD XX million/billion by 2022.
What is the CAGR of the Market?
The is to grow at a CAGR of 5.3% during the forecast by 2032.
What is the Market segment?
On the basis of type, the is segmented into Types.